Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 26, 2021
Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblastsDennis Chun-Yu Ho, Szu-Han Chen, Chih-Yuan Fang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 25, 2018
miR-145 mediates the anti-cancer stemness effect of photodynamic therapy with 5-aminolevulinic acid (ALA) in oral cancer cellsChih-Yuan Fang, Pei-Yin Chen, Dennis Chun-Yu Ho, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 26, 2021
Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1Po-Yu Yang, Dennis Chun-Yu Ho, Szu-Han Chen, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 13, 2021
Honokiol inhibits arecoline-induced oral fibrogenesis through transforming growth factor-β/Smad2/3 signaling inhibitionPei-Yin Chen, Dennis Chun-Yu Ho, Yi-Wen Liao, et al.Head & Neck|December 14, 2020
Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort studyWen-Chi Liu, Hsueh-Erh Liu, Yi-Wei Kao, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2020
miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosisChih-Yuan Fang, Cheng-Chia Yu, Yi-Wen Liao, et al.Environmental Toxicology|April 18, 2018
Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosisTzu-Rong Su, Yi-Wen Liao, Pei-Ling Hsieh, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2020
Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort studyWen-Chi Liu, Hsueh-Erh Liu, Yi-Wei Kao, et al.Oral Oncology|August 16, 2012
Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancerPen-Yuan Chu, Fang-Wei Hu, Cheng-Chia Yu, et al.Cancer Research|April 4, 2013
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancerCheng-Chia Yu, Lo-Lin Tsai, Mong-Lien Wang, et al.Pageof 5